BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3621224)

  • 1. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
    Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
    Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 6. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

  • 7. Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
    Gundersen S
    Cancer Treat Rep; 1987 Nov; 71(11):997-9. PubMed ID: 3677119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Cheung T; Holland JF
    Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B.
    Carey RW; Anderson JR; Green M; Ellison RR; Nathanson L; Kennedy BJ
    Cancer Treat Rep; 1986 Mar; 70(3):329-31. PubMed ID: 2420443
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
    Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
    Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.